Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Clinical Status Human RCT | Observational | Animal | In vitro Primarily studied in preclinical and regional aging research contexts, with limited exploratory human data
Rest the weekends to allow the peptide and body to reset
ProHealth's cited clinical study (Dosz E et al., Nutraceuticals, 2025) reported a 26.4% improvement in digestive comfort associated with ButyroGen at the ingredient level
PubMed Staresinic, M., Petek, M., Perovic, D., Coric, V., Zoricic, I., Zoricic, Z., & Sikiric, P
The potential for gastrointestinal adverse effects, particularly nausea and vomiting, may lead to dehydration and worsening of renal function in vulnerable patients
US$ 21.65
US$ 24.27
US$ 27.27
US$ 26.27
US$ 21.80
